<DOC>
	<DOCNO>NCT02294448</DOCNO>
	<brief_summary>Qishe Pill ( Shanghai Sundise Traditional Chinese Medicine Co. , Ltd , China ) , compose process Radix Astragali , Muscone , Szechuan Lovage Rhizome , Radix Stephaniae Tetrandrae , Ovientvine , Calculus Bovis Artifactus , develop spread use clinical setting 2009 . As individualization become trend modern medicine , personalized medicine Qishe Pill document practiced various patient accord ancient TCM system , classification personalize constitution type , establish determine predisposition prognosis diseases well therapy life-style administration . Therefore , describe population pharmacokinetic profile Qishe Pill compare extent metabolism 3 major Constitution Type ( Qi-Deficiency , Yin-Deficiency Blood-Stasis ) address major challenge individualize standardized Traditional Chinese Medicine clinical practice .</brief_summary>
	<brief_title>PopPK Profile Qishe Pill : Study Protocol Phase I Clinical Trial</brief_title>
	<detailed_description>With greatly increase morbidity neck pain , bring large challenge optimal therapy various situation population give time base demographic , physiological pathological characteristic . Chinese proprietary herbal medicine , kind Complementary Alternative Medicine ( CAM ) , usually develop well-established long-standing recipe formulate tablet capsule commerce , convenience palatability . Although advantage mention , good quantification strict standardization detail still need improved individualized implementation therapeutic strategy . Based YQHY decoction ( Yi-Qi Hua-Yu Decoction , tonify Qi promote circulation remove stasis ) , Qishe Pill ( Shanghai Sundise Traditional Chinese Medicine Co. , Ltd , China ) develop spread use clinical setting 2009 . As individualization become trend modern medicine , personalized medicine Qishe Pill document practiced various patient accord ancient TCM system , classification personalize constitution type , establish determine predisposition prognosis diseases well therapy life-style administration . Therefore , describe population pharmacokinetic profile Qishe Pill compare extent metabolism 3 major Constitution Type ( Qi-Deficiency , Yin-Deficiency Blood-Stasis ) address major challenge individualize standardized Traditional Chinese Medicine clinical practice .</detailed_description>
	<criteria>Inclusion Aged 2035 18.5 kg/m2 ≤Body mass index ( BMI ) &lt; 23 kg/m2 TCMconstitutionally type either 3 major type Exclusion History impair fast glucose diabetes mellitus ( past history diabetes fast blood glucose screen ≥100 mg/dl ) History liver disease ( hepatitis , hepatic cirrhosis ) hepatic dysfunction ( AST ALT screen ≥40 U/L ) History renal dysfunction ( creatinine screen ≥1.2 mg/dl ) History heart disease ( heart failure , angina pectoris , myocardial infarction , arrhythmia ) History malignant tumor Having digestive disorder interfere normal absorption standard diet ( gastritis , gastric ulcer , duodenitis , duodenal ulcer , etc . ) Smoking recent 3 month Alcohol consumption 3 time week recent 3 month Women pregnant , intend become pregnant , breast feeding Medicated recent month therapeutic prophylactic purpose Participating another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Cervical radiculopathy</keyword>
	<keyword>Neck pain</keyword>
	<keyword>Qishe pill</keyword>
	<keyword>raditional Chinese medicine</keyword>
	<keyword>healthy Chinese subject</keyword>
	<keyword>Population Pharmacokinetics</keyword>
	<keyword>Personalized Medicine</keyword>
	<keyword>Individualized Medicine</keyword>
</DOC>